title: Interactions of Na+,K+-ATPase and co-expressed delta-opioid receptor.
abstract: To investigate interference of delta-opioid receptor with the Na(+),K(+)-ATPase in a simple model system, we used the Xenopus oocytes as an expression system. Our results indicate that expression of the delta-opioid receptor (DOR) results in reduction of endogenous sodium-pump activity. Stimulation of DOR by the DOR agonist [(D)-Pen(2,5)]-enkephalin (DPDPE) had no pronounced additional effect on pump activity. Qualitatively similar results were obtained in experiments with a variety of co-expressed exogenous sodium pumps. We suggest that reduced pump activity with DOR expression is brought about by an interaction of the pump with DOR. Direct interaction is also supported by co-immunoprecipitation, not only in the Xenopus oocytes but also in rat hippocampal neurons. The interaction may be responsible for altered agonist sensitivity of DOR; activation of the sodium pump led to an increase of the K(m) value for DOR activation by DPDPE from about 0.17 to 0.27muM. In conclusion, pump activity not only affects neural activity directly but our results also suggest that pump activity is affected through functional interaction with DOR that will modulate pain sensation.
authors.affiliation: Shanghai Research Center for Acupuncture and Meridians, China.
authors.forename: Haiping
authors.initials: H
authors.lastname: Deng
authors.forename: Zhijie
authors.initials: Z
authors.lastname: Yang
authors.forename: Yuting
authors.initials: Y
authors.lastname: Li
authors.forename: Guobin
authors.initials: G
authors.lastname: Bao
authors.forename: Thomas
authors.initials: T
authors.lastname: Friedrich
authors.forename: Quanbao
authors.initials: Q
authors.lastname: Gu
authors.forename: Xueyong
authors.initials: X
authors.lastname: Shen
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Schwarz
mesh_terms: D000701:Analgesics, Opioid / Q000494:pharmacology; D000818:Animals; D002462:Cell Membrane / Q000187:drug effects / Q000378:metabolism* / Q000648:ultrastructure; D015536:Down-Regulation / Q000187:drug effects / Q000502:physiology; D020881:Enkephalin, D-Penicillamine (2,5)- / Q000494:pharmacology; D004789:Enzyme Activation / Q000187:drug effects / Q000502:physiology; D005260:Female; D006624:Hippocampus / Q000166:cytology / Q000378:metabolism; D008564:Membrane Potentials / Q000502:physiology; D009474:Neurons / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D009865:Oocytes / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure; D010146:Pain / Q000378:metabolism / Q000503:physiopathology; D018408:Patch-Clamp Techniques; D051381:Rats; D017465:Receptors, Opioid, delta / Q000378:metabolism*; D012964:Sodium / Q000378:metabolism; D000254:Sodium-Potassium-Exchanging ATPase / Q000378:metabolism*; D014982:Xenopus laevis
chemical_list: D000701:Analgesics, Opioid; D017465:Receptors, Opioid, delta; D020881:Enkephalin, D-Penicillamine (2,5)-; D012964:Sodium; D000254:Sodium-Potassium-Exchanging ATPase